Pay in 4 interest-free payments of $6.47 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Translating laboratory-discovered resistance-reversal strategies into clinical practice faces multiple barriers, including biological complexity, economic constraints, data integration challenges, ethical concerns, and unequal access to advanced diagnostics and personalized therapies
For instance, China currently dominates downstream processing of REE (Dushyantha et al
L-carnitine in cardiogenic shock therapy: pharmacodynamic aspects and clinical data
References 1 AbouM
US$ 27.70
US$ 27.36
US$ 25.64
US$ 29.00
US$ 24.29
US$ 25.46
US$ 28.49
